Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Search Results
6 results
Filters applied: . Clear all
Results are displayed in a computed author sort order.
The Results By Year timeline is not available.
Page 1
Real-World Study: Hybrid Immunity against SARS-CoV-2 Influences the Antibody Levels and Persistency Lasting More than One Year.
Vaccines (Basel). 2023 Nov 7;11(11):1693. doi: 10.3390/vaccines11111693.
Vaccines (Basel). 2023.
PMID: 38006025
Free PMC article.
Seroprevalence of SARS-CoV-2 anti-nucleocapsid total Ig, anti-RBD IgG antibodies, and infection in Thailand: a cross-sectional survey from October 2022 to January 2023.
Chansaenroj J, Suntronwong N, Kanokudom S, Assawakosri S, Vichaiwattana P, Klinfueng S, Wongsrisang L, Thongmee T, Aeemjinda R, Khanarat N, Srimuan D, Thatsanathorn T, Yorsaeng R, Katanyutanon A, Thanasopon W, Bhunyakitikorn W, Sonthichai C, Angsuwatcharakorn P, Withaksabut W, Wanlapakorn N, Sudhinaraset N, Poovorawan Y.
Chansaenroj J, et al. Among authors: aeemjinda r.
Sci Rep. 2023 Sep 20;13(1):15595. doi: 10.1038/s41598-023-42754-2.
Sci Rep. 2023.
PMID: 37730917
Free PMC article.
Item in Clipboard
SARS-CoV-2 Antibody Dynamics after COVID-19 Vaccination and Infection: A Real-World Cross-Sectional Analysis.
Yorsaeng R, Atsawawaranunt K, Suntronwong N, Kanokudom S, Chansaenroj J, Assawakosri S, Nilyanimit P, Aeemjinda R, Khanarat N, Wongsrisang L, Auphimai C, Vichaiwattana P, Klinfueng S, Thongmee T, Srimuan D, Thatsanathorn T, Sudhinaraset N, Wanlapakorn N, Poovorawan Y.
Yorsaeng R, et al. Among authors: aeemjinda r.
Vaccines (Basel). 2023 Jun 30;11(7):1184. doi: 10.3390/vaccines11071184.
Vaccines (Basel). 2023.
PMID: 37515001
Free PMC article.
Item in Clipboard
Comparison of the reactogenicity and immunogenicity between two-dose mRNA COVID-19 vaccine and inactivated COVID-19 vaccine followed by an mRNA vaccine in children aged 5-11 years.
Wanlapakorn N, Kanokudom S, Phowatthanasathian H, Chansaenroj J, Suntronwong N, Assawakosri S, Yorsaeng R, Nilyanimit P, Vichaiwattana P, Klinfueng S, Thongmee T, Aeemjinda R, Khanarat N, Srimuan D, Thatsanatorn T, Chantima W, Pakchotanon P, Duangchinda T, Sudhinaraset N, Poovorawan Y.
Wanlapakorn N, et al. Among authors: aeemjinda r.
J Med Virol. 2023 May;95(5):e28758. doi: 10.1002/jmv.28758.
J Med Virol. 2023.
PMID: 37212319
Item in Clipboard
The Fourth Dose of mRNA COVID-19 Vaccine Following 12 Different Three-Dose Regimens: Safety and Immunogenicity to Omicron BA.4/BA.5.
Kanokudom S, Chansaenroj J, Suntronwong N, Assawakosri S, Yorsaeng R, Nilyanimit P, Aeemjinda R, Khanarat N, Vichaiwattana P, Klinfueng S, Thongmee T, Srimuan D, Thatsanathorn T, Sudhinaraset N, Wanlapakorn N, Honsawek S, Poovorawan Y.
Kanokudom S, et al. Among authors: aeemjinda r.
Vaccines (Basel). 2023 Mar 1;11(3):570. doi: 10.3390/vaccines11030570.
Vaccines (Basel). 2023.
PMID: 36992154
Free PMC article.
Item in Clipboard
Safety and immunogenicity of a third dose of COVID-19 protein subunit vaccine (CovovaxTM) after homologous and heterologous two-dose regimens.
Kanokudom S, Chansaenroj J, Suntronwong N, Assawakosri S, Yorsaeng R, Nilyanimit P, Aeemjinda R, Khanarat N, Vichaiwattana P, Klinfueng S, Thongmee T, Katanyutanon A, Thanasopon W, Arayapong J, Withaksabut W, Srimuan D, Thatsanatorn T, Sudhinaraset N, Wanlapakorn N, Honsawek S, Poovorawan Y.
Kanokudom S, et al. Among authors: aeemjinda r.
Int J Infect Dis. 2023 Jan;126:64-72. doi: 10.1016/j.ijid.2022.11.022. Epub 2022 Nov 22.
Int J Infect Dis. 2023.
PMID: 36427701
Free PMC article.
Item in Clipboard
Cite
Cite